Assignee
TOOLGEN INC
KR·19 granted patents·42 pending applications·95 citations·filing 2003–2025
Top patents by PatentIndex Score
61 records- 0197US10851380B2Methods for cleaving a target DNA using a guide RNA specific for the target DNA and Cas protein-encoding nucleic acid or Cas proteinTOOLGEN INC·Filed 2015·Granted Dec 1, 2020·47 cites·10 claims
- 0296US10519454B2Genome editing using Campylobacter jejuni CRISPR/CAS system-derived RGENTOOLGEN INC·Filed 2017·Granted Dec 31, 2019·15 cites·13 claims
- 0391US7514257B2Zinc finger transcription factor differentiation proteinsTOOLGEN INC·Filed 2003·Granted Apr 7, 2009·32 cites·15 claims
- 0491US2025066798A1Compositions for inducing modifications of target endogenous nucleic acid sequences in nucleuses of eukaryotic cellsTOOLGEN INC·Filed 2024·Application pending·0 cites
- 0591US2025122509A1Compositions for Inducing Modifications of Target Endogenous Nucleic Acid Sequences in Nucleuses of Eukaryotic CellsTOOLGEN INC·Filed 2024·Application pending·0 cites
- 0689US12473559B2Cas9/RNA complexes for inducing modifications of target endogenous nucleic acid sequences in nucleuses of eukaryotic cellsTOOLGEN INC·Filed 2023·Granted Nov 18, 2025·0 cites·8 claims
- 0786US2023374525A1Composition for cleaving a target dna comprising a guide rna specific for the target dna and cas protein-encoding nucleic acid or cas protein, and use thereofTOOLGEN INC·Filed 2023·Application pending·0 cites
- 0886US2023374524A1Composition for cleaving a target dna comprising a guide rna specific for the target dna and cas protein-encoding nucleic acid or cas protein, and use thereofTOOLGEN INC·Filed 2023·Application pending·0 cites
- 0983US12509697B2Oleic acid-enriched plant body having genetically modified FAD2 and production method thereofTOOLGEN INC·Filed 2023·Granted Dec 30, 2025·0 cites·1 claims
- 1077US2025171788A1Compositions for Inducing Modifications of Target Endogenous Nucleic Acid Sequences in Nucleuses of Eukaryotic CellsTOOLGEN INC·Filed 2025·Application pending·0 cites
- 1176US2026043013A1Single base substitution protein, and composition comprising sameTOOLGEN INC·Filed 2025·Application pending·0 cites
- 1275US2025146002A1Compositions for Inducing Modifications of Target Endogenous Nucleic Acid Sequences in Nucleuses of Eukaryotic CellsTOOLGEN INC·Filed 2025·Application pending·0 cites
- 1375US2021047647A1Composition for cleaving a target dna comprising a guide rna specific for the target dna and cas protein-encoding nucleic acid or cas protein, and use thereofTOOLGEN INC·Filed 2020·Application pending·0 cites
- 1475US2021047648A1Composition for cleaving a target dna comprising a guide rna specific for the target dna and cas protein-encoding nucleic acid or cas protein, and use thereofTOOLGEN INC·Filed 2020·Application pending·0 cites
- 1574US12486521B2Platform for expressing protein of interest in liverTOOLGEN INC·Filed 2023·Granted Dec 2, 2025·0 cites·13 claims
- 1674US12286635B2Oleic acid-enriched plant body having genetically modified FAD2 and production method thereofTOOLGEN INC·Filed 2022·Granted Apr 29, 2025·0 cites·7 claims
- 1772US11441135B2Target-specific CRISPR mutantTOOLGEN INC·Filed 2018·Granted Sep 13, 2022·1 cites·6 claims
- 1871US2024301424A1Manipulated immunoregulatory element and immunity altered therebyTOOLGEN INC·Filed 2024·Application pending·0 cites
- 1969US12163149B2Artificial genome manipulation for gene expression regulationTOOLGEN INC·Filed 2022·Granted Dec 10, 2024·0 cites·5 claims
- 2068US2015284727A1Composition for cleaving a target dna comprising a guide rna specific for the target dna and cas protein-encoding nucleic acid or cas protein, and use thereofTOOLGEN INC·Filed 2013·Application pending·0 cites
- 2167US2025290054A1Target-specific crispr mutantTOOLGEN INC·Filed 2025·Application pending·0 cites
- 2266US11999952B2Artificially-manipulated neovascularization regulatory systemTOOLGEN INC·Filed 2021·Granted Jun 4, 2024·0 cites·11 claims
- 2366US2025064861A1Cells for intravascular transplantation having hemocompatibility, method of producing same, and use thereofTOOLGEN INC·Filed 2024·Application pending·0 cites
- 2463US2025215488A1Method for predicting off-target which can occur in process of editing genome by using prime editing systemTOOLGEN INC·Filed 2023·Application pending·0 cites
- 2563US2024166999A1Hemocompatible mesenchymal stem cells, preparation method therefor and use thereofTOOLGEN INC·Filed 2024·Application pending·0 cites
- 2663US2024216539A1Vector for delivering active agent to nervous system, and use thereofTOOLGEN INC·Filed 2024·Application pending·0 cites
- 2763US2025000912A1Hypoimmunogenic stem cells, hypoimmunogenic cells differentiated or derived from stem cells and method of preparing sameTOOLGEN INC·Filed 2024·Application pending·0 cites
- 2862US2022228133A1Single base substitution protein, and composition comprising sameTOOLGEN INC·Filed 2020·Application pending·0 cites
- 2962US2023130858A1Target-specific crispr mutantTOOLGEN INC·Filed 2022·Application pending·0 cites
- 3062US2024139254A1Mesenchymal stem cell having oxidative stress resistance, preparation method therefor, and use thereofTOOLGEN INC·Filed 2024·Application pending·0 cites
- 3162US2020172912A1Genome editing using campylobacter jejuni crispr/cas system-derived rgenTOOLGEN INC·Filed 2019·Application pending·0 cites
- 3261US2025327120A1Method for predicting possible off-targets in gene editing processTOOLGEN INC·Filed 2023·Application pending·0 cites
- 3361US2025115906A1Schwann cell-specific promoterTOOLGEN INC·Filed 2023·Application pending·0 cites
- 3460US11572574B2Artificial genome manipulation for gene expression regulationTOOLGEN INC·Filed 2020·Granted Feb 7, 2023·0 cites·15 claims
- 3560US2023190889A1Gene editing of anticoagulant factorsTOOLGEN INC·Filed 2023·Application pending·0 cites
- 3659US2025154479A1Streptococcus pyogenes-derived cas9 variantTOOLGEN INC·Filed 2023·Application pending·0 cites
- 3759US2023416315A1Prion-fc region fusion protein and use thereofTOOLGEN INC·Filed 2021·Application pending·0 cites
- 3858US12351838B2Target-specific CRISPR mutantTOOLGEN INC·Filed 2019·Granted Jul 8, 2025·0 cites·11 claims
- 3958US11667934B2Platform for expressing protein of interest in liverTOOLGEN INC·Filed 2018·Granted Jun 6, 2023·0 cites·15 claims
- 4057US2025146003A1Compositions for Inducing Modifications of Target Endogenous Nucleic Acid Sequences in Nucleuses of Eukaryotic CellsTOOLGEN INC·Filed 2025·Application pending·0 cites
- 4157US2020208166A1Oleic Acid-Enriched Plant Body Having Genetically Modified FAD2 And Production Method ThereofTOOLGEN INC·Filed 2017·Application pending·0 cites
- 4254US2025051749A1Novel promoter and use thereofTOOLGEN INC·Filed 2022·Application pending·0 cites
- 4354US2009176653A1Zinc finger domain librariesTOOLGEN INC·Filed 2008·Application pending·0 cites
- 4454US2025283102A1METHOD FOR PRODUCING POTATO PLANT WITH SUPPRESSED BROWNING USING CRISPR/Cas9 SYSTEMTOOLGEN INC·Filed 2021·Application pending·0 cites
- 4553US12331086B2Artificially engineered SC function control systemTOOLGEN INC·Filed 2017·Granted Jun 17, 2025·0 cites·5 claims
- 4652US2023063739A1Cells having high adaptability under hypoxic conditions, and use thereofTOOLGEN INC·Filed 2021·Application pending·0 cites
- 4750US2006251643A1Regulatory zinc finger proteinsTOOLGEN INC·Filed 2003·Application pending·0 cites
- 4849US12012598B2Manipulated immunoregulatory element and immunity altered therebyTOOLGEN INC·Filed 2017·Granted Jun 18, 2024·0 cites·4 claims
- 4948US12275963B2Artificially manipulated immune cellTOOLGEN INC·Filed 2018·Granted Apr 15, 2025·0 cites·13 claims
- 5048US2018237771A1Artificially-Manipulated Neovascularization Regulatory SystemTOOLGEN INC·Filed 2018·Application pending·0 cites
Showing the top 50 of 61 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when TOOLGEN INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →